Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2024, Vol. 38 ›› Issue (3): 55-60.doi: 10.6040/j.issn.1673-3770.0.2023.504

• Original Article • Previous Articles    

Clinical observation of compacept in the treatment of diabetes mellitus with CRVO-ME high reflex point

BAO Ying1,2, LIU Zhigao2, JANG Pengfei3, CUI Wenxuan1, ZHENG Xiaoxia1, YANG Mengyao1, SI Mingwei1, WANG Yu2,4, WANG Hong1   

  1. 1. Department of Ophthalmology, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China2. Jinan Aier Eye Hospital, Jinan 250100, Shandong, China3. Department of Ophthalmology, Yantai Yuhuangding Hospital, Yantai 264099, Shandong, China4. The Second People's Hospital of Jinan, Jinan 250001, Shandong, China
  • Published:2024-06-04

PDF (PC)

203

Abstract: Objective To observe the changes in hyperreflective dots(HRD)in the retina of patients with non-ischemic central retinal vein occlusion-macular edema(CRVO-ME)treated with conbercept. Methods Eighty cases and 80 eyes of non-ischemic CRVO-ME patients were selected and divided into 40 cases(40 eyes)in the diabetic group and 40 cases(40 eyes)in the non-diabetic group according to the presence or absence of diabetes mellitus. Best corrected visual acuity(BCVA), central macular thickness(CMT)and the number of HRDs in the inner and outer retinal layers were compared and analysed in the two groups before and 1, 3 and 6 months after intravitreal injection of conbercept(IVC)treatment. Results At 3 and 6 months after IVC, BCVA in the non-diabetic group was significantly higher than that in the diabetic group(F=4.106,P=0.046;F=10.474,P=0.002), and CMT was significantly lower at 6 months after IVC(F=10.688,P=0.002). There was no significant difference in the amount of HRD in the inner retina between the two groups before and after IVC(F=1.608,P=0.209), but there was a significant difference in the amount of HRD in the outer retina(F=4.290,P=0.042). Conclusion IVC is effective in the treatment of non-ischemic CRVO-ME. HRD in the outer layer of the retina can be used as an imaging marker to monitor the inflammatory response and assess prognosis. The long-term therapeutic effect of non-ischemic CRVO-ME in diabetic group is worse than in non-diabetic group. Therefore, more attention should be paid to the long-term follow-up of diabetic patients to avoid serious complications.

Key words: Diabetes, Non-ischemic central retinal vein occlusion, Intravitreal injection, Macular edema, High reflective points

CLC Number: 

  • R587.1
[1] Chang YS, Ho CH, Chu CC, et al. Risk of retinal vein occlusion in patients with diabetes mellitus: a retrospective cohort study[J]. Diabetes Res Clin Pract, 2021, 171: 108607. doi:10.1016/j.diabres.2020.108607
[2] Ehlers JP, Fekrat S. Retinal vein occlusion: beyond the acute event[J]. Surv Ophthalmol, 2011, 56(4): 281-299. doi:10.1016/j.survophthal.2010.11.006
[3] Lin J, Gibbons A, Smiddy WE. Cost-utility of anti-vascular endothelial growth factor treatment for macular edema secondary to central retinal vein occlusion[J]. Ophthalmol Retina, 2021, 5(7): 656-663. doi:10.1016/j.oret.2020.09.017
[4] Ciulla TA, Kapik B, Hu A, et al. Anatomic biomarkers of macular edema associated with retinal vein occlusion[J]. Ophthalmol Retina, 2022, 6(12): 1206-1220. doi:10.1016/j.oret.2022.06.016
[5] Tang FS, Qin XH, Lu JM, et al. Optical coherence tomography predictors of short-term visual acuity in eyes with macular edema secondary to retinal vein occlusion treated with intravitreal conbercept[J]. Retina, 2020, 40(4): 773-785. doi:10.1097/IAE.0000000000002444
[6] Hwang HS, Chae JB, Kim JY, et al. Association between hyperreflective dots on spectral-domain optical coherence tomography in macular edema and response to treatment[J]. Invest Ophthalmol Vis Sci, 2017, 58(13): 5958-5967. doi: 10.1167/iovs.17-22725
[7] Do JR, Park SJ, Shin JP, et al. Assessment of hyperreflective foci after bevacizumab or dexamethasone treatment according to duration of macular edema in patients with branch retinal vein occlusion[J]. Retina, 2021, 41(2): 355-365. doi:10.1097/IAE.0000000000002826
[8] Schreur V, Altay L, van Asten F, et al. Hyperreflective foci on optical coherence tomography associate with treatment outcome for anti-VEGF in patients with diabetic macular edema[J]. PLoS One, 2018, 13(10): e0206482. doi: 10.1371/journal.pone.0206482
[9] American diabetes association. Standards of medical care in diabetes-2010[J]. Diabetes Care, 2010, 33(Suppl 1): S11-S61. doi: 10.2337/dc10-S011
[10] 杨培增, 范先群. 眼科学[M]. 9版. 北京: 人民卫生出版社, 2018: 191-193
[11] 魏文斌, 陈积中. 眼底病鉴别诊断学[M]. 北京: 人民卫生出版社, 2012: 181-186
[12] Chatziralli IP, Sergentanis TN, Sivaprasad S. Hyperreflective foci as an independent visual outcome predictor in macular edema due to retinal vascular diseases treated with intravitreal dexamethasone or ranibizumab[J]. Retina, 2016, 36(12): 2319-2328. doi:10.1097/IAE.0000000000001070
[13] 邓玉梦, 宋艳萍, 黄珍, 等. 年龄和OCT特征与抗VEGF治疗视网膜中央静脉阻塞性黄斑水肿效果的相关性[J]. 国际眼科杂志, 2021, 21(6): 1062-1067. doi:10.3980/j.issn.1672-5123.2021.6.25 DENG Yumeng, SONG Yanping, HUANG Zhen, et al. Correlation of age and OCT features with efficacy of anti-VEGF agents for macular edema secondary to central retinal vein occlusion[J]. International Eye Science, 2021, 21(6): 1062-1067. doi:10.3980/j.issn.1672-5123.2021.6.25
[14] Nicholson L, Talks SJ, Amoaku W, et al. Retinal vein occlusion(RVO)guideline: executive summary[J]. Eye, 2022, 36(5): 909-912. doi:10.1038/s41433-022-02007-4
[15] Trovato Battagliola E, Pacella F, Malvasi M, et al. Risk factors in central retinal vein occlusion: a multi-center case-control study conducted on the Italian population: demographic, environmental, systemic, and ocular factors that increase the risk for major thrombotic events in the retinal venous system[J]. Eur J Ophthalmol, 2022, 32(5): 2801-2809. doi:10.1177/11206721211064469
[16] Tomkins M, Lawless S, Martin-Grace J, et al. Diagnosis and management of central diabetes insipidus in adults[J]. J Clin Endocrinol Metab, 2022, 107(10): 2701-2715. doi:10.1210/clinem/dgac381
[17] O’Mahoney PRA, Wong DT, Ray JG. Retinal vein occlusion and traditional risk factors for atherosclerosis[J]. Arch Ophthalmol, 2008, 126(5): 692-699. doi:10.1001/archopht.126.5.692
[18] Wang Y, Wu SJ, Wen F, et al. Diabetes mellitus as a risk factor for retinal vein occlusion: a meta-analysis[J]. Medicine, 2020, 99(9): e19319. doi:10.1097/MD.0000000000019319
[19] Elman MJ. All patients treated for proliferative diabetic retinopathy need to be monitored carefully over time for further treatment[J]. Ophthalmology, 2021, 128(10): 1458-1459. doi:10.1016/j.ophtha.2021.07.019
[20] Yong H, Qi H, Yan H, et al. The correlation between cytokine levels in the aqueous humor and the prognostic value of anti-vascular endothelial growth factor therapy for treating macular edema resulting from retinal vein occlusion[J]. Graefes Arch Clin Exp Ophthalmol, 2021, 259(11): 3243-3250. doi: 10.1007/s00417-021-05211-2
[21] Zhu C, Pan L, Yi Q, et al. Analysis of the cytokine expression in the aqueous humor of individuals with BRVO-associated macular edema[J]. J Ophthalmol, 2022: 1514244. doi: 10.1155/2022/1514244
[22] 赵晶. 玻璃体腔注射康柏西普治疗糖尿病眼底病变合并视网膜静脉阻塞黄斑水肿的临床效果分析[J]. 现代诊断与治疗, 2022, 33(4): 511-513 ZHAO Jing. Clinical effect analysis of intravitreal injection of Compaxip in the treatment of diabetic fundus diseases complicated with retinal vein occlusion and macular edema[J]. Modern Diagnosis and Treatment, 2022, 33(4): 511-513
[23] 韩克阳, 于贝贝, 赵博军. 短期视网膜静脉阻塞抗VEGF治疗后黄斑区形态结构分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(5): 129-131. doi:10.6040/j.issn.1673-3770.0.2017.515 HAN Keyang, YU Beibei, ZHAO Bojun. Morphological structure analysis of the macular area after anti-VEGF treatment for short-term retinal vein occlusion[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(5): 129-131. doi:10.6040/j.issn.1673-3770.0.2017.515
[24] Coscas G, Loewenstein A, Augustin A, et al. Management of retinal vein occlusion: consensus document[J]. Ophthalmologica, 2011, 226(1): 4-28. doi:10.1159/000327391
[25] Fong AHC, Li KKW, Wong D. Choroidal evaluation using enhanced depth imaging spectral-domain optical coherence tomography in Vogt-Koyanagi-Harada disease[J]. Retina, 2011, 31(3): 502-509. doi:10.1097/IAE.0b013e3182083beb
[26] Lee SM, Kwon HJ, Park SW, et al. Instrumental difference in assessing choroidal hyperpermeability and photodynamic therapy in chronic central serous chorioretinopathy[J]. Retina, 2019, 39(7): 1361-1369. doi:10.1097/IAE.0000000000002150
[27] Vujosevic S, Bini S, Midena G, et al. Hyperreflective intraretinal spots in diabetics without and with nonproliferative diabetic retinopathy: an in vivo study using spectral domain OCT[J]. J Diabetes Res, 2013: 491835. doi:10.1155/2013/491835
[28] Mizukami T, Hotta Y, Katai N. Higher numbers of hyperreflective foci seen in the vitreous on spectral-domain optical coherence tomographic images in eyes with more severe diabetic retinopathy[J]. Ophthalmologica, 2017, 238(1/2): 74-80. doi:10.1159/000473886
[29] Ebneter A, Kokona D, Schneider N, et al. Microglia activation and recruitment of circulating macrophages during ischemic experimental branch retinal vein occlusion[J]. Invest Ophthalmol Vis Sci, 2017, 58(2): 944-953. doi:10.1167/iovs.16-20474
[1] ZHOU Jinglin, LI Jinxiang, ZENG Qi. Effect of 577 nm subthreshold micropulse laser photocoagulation combined with anti-VEGF on the treatment of refractory diabetic macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 18-25.
[2] HE Jing, LEI Chunyan, ZHANG Meixia. Association of glycosylated hemoglobin variation index with diabetic retinopathy severity [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 34-40.
[3] LI Shuting, ZHAO Hui, SI Mingwei, CUI Wenxuan, YANG Mengyao, WANG Hong. Fungal endophthalmitis in a patient with no history of vegetative trauma: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 103-108.
[4] LU Gan, DENG Yuqin, TAO Zezhang. Relationship between allergic diseases and diabetes mellitus and underlying mechanisms [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 215-222.
[5] SONG Huarong, TANG Guanghua, ZHU Renliang. A case report of rhino-orbitocerebral mucormycosis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(6): 96-100.
[6] GU Ranran, LI Fengjiao, JIAO Wanzhen, CUI Yanyan, ZHAO Bojun. Clinical efficacy of lecithin complex iodine capsule in the adjuvant treatment of retinal vein occlusion [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(5): 46-50.
[7] TIAN Jun, LIU Liangfa, BAI Jiaqi. Cervical vertebral osteomyelitis secondary to necrotizing otitis externa:a case report and review of literature [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(4): 1-5.
[8] WANG Hui, WANG Jun, SUN Yi, YU Tengfei, ZHU Yuguang, ZHU Yan. Effect of intravitreal injection of HGF-MSCs on the expression of HGF in retina tissue of diabetic rats [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 72-77.
[9] Keyang HAN,Beibei YU,Bojun ZHAO. Morphological structure analysis of the macular area after anti-VEGF treatment for short-term retinal vein occlusion [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(5): 129-131.
[10] LIU Jianbo, ZHANG Huan. Phacoemulsification combined with intravitreal ranibizumab or triamcinolone acetonide injection for the treatment of cataract accompanied by diabetic macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 99-104.
[11] ZHANG Ying, CHEN Hongmei, WU Xinyi.. Delayed corneal wound healing is related to impaired IGF-1 expression in diabetic rats. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(6): 74-78.
[12] . Clinical observation on the treatment of CSME and NCSME by intravitreal injection of ranibizumab. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(2): 96-98.
[13] . Clinical observation on the treatment of BRVO-ME by the combination of laser therapy with Ranibizumab intravitreal injection. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(1): 110-113.
[14] . The pathogenesis of RVO and anti-VEGF treatment for its macular edema. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(1): 123-126.
[15] YAN Xiaoteng, FENG Jun, KANG Xinle. Intravitreal injection of conbercept for macular edema secondary to retinal vein occlusion. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(4): 105-108.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd